Predictors of response to immune checkpoint inhibition in a real world gynecologic cancer population()

Prognostic factors for immune checkpoint inhibitor (CPI) response in gynecologic cancer are limited. This retrospective study aimed to identify prognostic factors associated with improved overall response rate (ORR) and progression free survival (PFS) in gynecologic cancer patients receiving at leas...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuznicki, Michelle L., Bennett, Carrie, Yao, Meng, Joehlin-Price, Amy, Rose, Peter G., Mahdi, Haider
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689517/
https://www.ncbi.nlm.nih.gov/pubmed/33294575
http://dx.doi.org/10.1016/j.gore.2020.100671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689517/
https://www.ncbi.nlm.nih.gov/pubmed/33294575
http://dx.doi.org/10.1016/j.gore.2020.100671

Ejemplares similares